---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-076933"
form_type: "8-K"
ticker: "ELOX"
cik: "0001035354"
company_name: "Eloxx Pharmaceuticals, Inc."
filed_at: "2025-08-12T23:59:59+00:00"
generated_at: "2026-05-17T14:12:28.359734+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Director Lindsay Androski resigns from Eloxx board effective August 6, 2025

## Summary
- Lindsay Androski notified the Board of her resignation, effective immediately on August 6, 2025.
- Resignation was not due to any disagreement with the Company's operations, policies, or practices.
- No replacement director has been announced; board size reduced accordingly.

## SEC filing metadata
- accession: 0001104659-25-076933
- form_type: 8-K
- ticker: ELOX
- cik: 0001035354
- company_name: Eloxx Pharmaceuticals, Inc.
- filed_at: 2025-08-12T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1035354/000110465925076933/0001104659-25-076933-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1035354/000110465925076933/tm2523236d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-076933
- JSON: https://secwatch.observer/filing/0001104659-25-076933.json
- Plain text: https://secwatch.observer/filing/0001104659-25-076933.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.